April 5, 2019

Life Science Tennessee Takes D.C.

This week, a team of Life Science Tennessee staff, board members, and members traveled to D.C. to meet with Tennessee's delegation to the U.S. Congress and advocate for the continued advancement of our industry.

We held a breakfast for our delegates that honored Senator Lamar Alexander (R-TN) with additional remarks from Rep. Phil Roe (R-TN-1) and Rep. Tim Burchett (R-TN-2). We also participated in eight legislative meetings that included Senator Marsha Blackburn (R-TN), Rep. Steve Cohen (D-TN-9) and Rep. Scott DesJarlais (R-TN-4), as well as a briefing with Senate Health, Education, Labor and Pensions Committee staff.

Again and again, we heard support for the innovations we create and recognition of the challenges facing our industry from the medical device tax, set to go into effect January 1 barring a repeal, and the debate over drug pricing and transparency. Read our federal policy recommendations.

Thank you to all who participated and made this a successful trip!

Tech Venture Challenge Final Pitch on Thursday

The Tech Venture Challenge, hosted by Vanderbilt University's Center for Technology Transfer & Commercialization, will conclude with the final pitch on April 11. The Tech Venture Challenge is an annual competition designed to provide networking and educational opportunities for Vanderbilt students from a variety of backgrounds including science, business, and law. Under the guidance of business mentors, the student-teams develop and present commercialization plans for Vanderbilt inventions and technologies.

Pitches will start at 6:00PM followed by a networking reception where the winner will be announced. Don't miss this opportunity to see innovative technologies in action--RSVP today!

LST News

In New Drug Cost Poll, Voters’ Top Concern is Lowering Out-of-Pocket Costs

As policymakers continue to examine ways to make prescription drugs more affordable, BIO has worked with Morning Consult in releasing new polling data that show voters’ views on prescription drug costs.

Key Takeaways:

When it comes to concerns about drug costs, 46% of voters say it’s most important for policymakers to lower what people are required by insurers to pay out of pocket for medicines.
Voters picked increased competition over price controls by a more than 2 to 1 margin when asked about the best way to lower drug costs for patients.

As BIO’s President and CEO Jim Greenwood noted:

"The American people want policymakers to focus on lowering what patients have to pay out of pocket for the medicines they need. This new polling data also shows that voters are not willing to accept misguided schemes like price controls that would hurt future innovation and restrict patient access, but rather see more market-based competition as the best solution.”

Become an LST Member

If you have company news or events to share with us, please send to:

Sara at spruneski@lifesciencetn.org

Manage your preferences | Opt out using TrueRemove®
Got this as a forward? Sign up to receive our future emails.
View this email online.

217 5th Avenue North Suite 200
Nashville, TN | 37219 US

This email was sent to .
To continue receiving our emails, add us to your address book.